117 related articles for article (PubMed ID: 23469910)
1. Calculating cardiac risk in obese adolescents before and after onset of lifestyle intervention.
Reinehr T
Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):297-306. PubMed ID: 23469910
[TBL] [Abstract][Full Text] [Related]
2. The effect of weight loss magnitude on pro-/anti-inflammatory adipokines and carotid intima-media thickness in obese adolescents engaged in interdisciplinary weight loss therapy.
Masquio DC; de Piano A; Sanches PL; Corgosinho FC; Campos RM; Carnier J; da Silva PL; Caranti DA; Tock L; Oyama LM; Oller do Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Clin Endocrinol (Oxf); 2013 Jul; 79(1):55-64. PubMed ID: 22809141
[TBL] [Abstract][Full Text] [Related]
3. Challenges and strategies in managing cardiometabolic risk.
Repas TB
J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
[TBL] [Abstract][Full Text] [Related]
4. Obesity and metabolic syndrome as related to cardiovascular disease.
Nikolopoulou A; Kadoglou NP
Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):933-9. PubMed ID: 22908926
[TBL] [Abstract][Full Text] [Related]
5. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
[TBL] [Abstract][Full Text] [Related]
6. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.
Després JP
J Endocrinol Invest; 2006; 29(3 Suppl):77-82. PubMed ID: 16751711
[TBL] [Abstract][Full Text] [Related]
7. Effects of lifestyle modification on adipocytokine levels in obese patients.
De Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; Perez Castrillon JL
Eur Rev Med Pharmacol Sci; 2008; 12(1):33-9. PubMed ID: 18401970
[TBL] [Abstract][Full Text] [Related]
8. The progression of cardiovascular risk to cardiovascular disease.
Rosin BL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular manifestations of insulin resistance.
Chahwala V; Arora R
Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
[TBL] [Abstract][Full Text] [Related]
11. Adipokines at the crossroad between obesity and cardiovascular disease.
Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
[TBL] [Abstract][Full Text] [Related]
12. Are there still healthy obese patients?
Blüher M
Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):341-6. PubMed ID: 22895358
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of lifestyle intervention in overweight children.
Reinehr T
Proc Nutr Soc; 2011 Nov; 70(4):494-505. PubMed ID: 21801473
[TBL] [Abstract][Full Text] [Related]
14. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
15. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
Misra A; Khurana L
Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors in adolescents: relevance, detection, and intervention.
McCrindle BW
Adolesc Med; 2001 Feb; 12(1):147-62. PubMed ID: 11224028
[TBL] [Abstract][Full Text] [Related]
17. Adipokines--targeting a root cause of cardiometabolic risk.
Bakhai A
QJM; 2008 Oct; 101(10):767-76. PubMed ID: 18550581
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of retinal endothelial dysfunction in obesity WHO class III.
Lammert A; Hasenberg T; Imhof I; Schnülle P; Benck U; Krämer BK; Hammes HP
Microvasc Res; 2012 Nov; 84(3):362-6. PubMed ID: 23009954
[TBL] [Abstract][Full Text] [Related]
19. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
Völler H; Schmailzl KJ; Bjarnason-Wehrens B
Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
[TBL] [Abstract][Full Text] [Related]
20. Weight loss induced by 6-month lifestyle intervention improves early endothelial activation and fibrinolysis in obese adolescents.
Huang F; del-Río-Navarro BE; de Castro GT; Alcántara ST; Sienra Monge JJ; Ontiveros JA; Olivos EN; Barron MF; Lopéz AR; Villafaña S; Hong E
Child Care Health Dev; 2011 May; 37(3):377-84. PubMed ID: 21198775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
